CME Group Inc. $CME Shares Acquired by Accretive Wealth Partners LLC

Accretive Wealth Partners LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 1.2% during the second quarter, Holdings Channel reports. The fund owned 7,493 shares of the financial services provider’s stock after purchasing an additional 90 shares during the quarter. Accretive Wealth Partners LLC’s holdings in CME Group were worth $2,065,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in CME. GAMMA Investing LLC boosted its stake in shares of CME Group by 24.5% during the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock valued at $1,859,000 after acquiring an additional 1,381 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in CME Group by 63.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider’s stock worth $27,867,000 after buying an additional 40,592 shares during the period. CWA Asset Management Group LLC lifted its position in CME Group by 31.2% during the first quarter. CWA Asset Management Group LLC now owns 1,147 shares of the financial services provider’s stock worth $304,000 after buying an additional 273 shares during the period. Advisor Resource Council purchased a new position in CME Group during the first quarter worth about $266,000. Finally, PFG Investments LLC lifted its position in CME Group by 167.2% during the first quarter. PFG Investments LLC now owns 3,247 shares of the financial services provider’s stock worth $861,000 after buying an additional 2,032 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several recent analyst reports. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Keefe, Bruyette & Woods increased their target price on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. TD Cowen increased their target price on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research report on Wednesday, October 8th. Jefferies Financial Group reduced their target price on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $283.71.

CME Group Stock Performance

CME Group stock opened at $267.93 on Monday. The stock’s 50-day moving average is $267.30 and its 200-day moving average is $271.40. The company has a market cap of $96.56 billion, a price-to-earnings ratio of 25.94, a price-to-earnings-growth ratio of 6.16 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $2.56 EPS. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.40%.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,043 shares of company stock valued at $3,527,956. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.